Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes

A target-specific effect or response to a low-frequency pattern of stimulation?

A. Stefani, M. Pierantozzi, R. Ceravolo, L. Brusa, S. Galati, Paolo Stanzione

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Deep brain stimulation (DBS) is a reliable treatment for advanced Parkinson's disease (PD) patients, but a possible risk of worsening cognitive functions, although modest, may postpone or halt DBS clinical indication. In a small cohort of PD patients we have pioneered the simultaneous implantation of both the subthalamic nucleus (STN) and the pedunculopontine tegmental nucleus (PPTg). Here we describe the cognitive test performance and the corresponding cortical metabolic activity, as assessed through 18-fluorodeoxyglucose (FDG)-positron emission tomography (PET), of these six PD patients tested in PPTg-ON vs- PPTg-OFF condition. PPTg-ON condition (at low frequency, 25 Hz) induced better performance in tests exploring both executive and attentive domains, which were coupled with an increased glucose utilization in prefrontal and frontal bilateral cortical areas, including both lateral (i.e., BA 9) and more antero-medial cortices (BA 25-32). Moreover, during PPTg-ON, a surprising increase of FDG consumption was also observed in the left ventral striatum. These data are consistent with the hypothesis of a positive effect of 25 Hz PPTg-DBS on PD patients' cognitive profile, probably due to a facilitatory effect exerted by PPTg on both associative and limbic pathways.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalClinical EEG and Neuroscience
Volume41
Issue number2
Publication statusPublished - Apr 2010

Fingerprint

Pedunculopontine Tegmental Nucleus
Deep Brain Stimulation
Parkinson Disease
Subthalamic Nucleus
Positron-Emission Tomography
Cognition
Glucose

Keywords

  • Deep brain stimulation
  • Low frequency stimulation
  • Parkinson's disease
  • Pedunculopontine tegmental area
  • Positron Emission Tomography (PET)

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes : A target-specific effect or response to a low-frequency pattern of stimulation? / Stefani, A.; Pierantozzi, M.; Ceravolo, R.; Brusa, L.; Galati, S.; Stanzione, Paolo.

In: Clinical EEG and Neuroscience, Vol. 41, No. 2, 04.2010, p. 82-86.

Research output: Contribution to journalArticle

@article{1c6c5964abc645eb8d5f0af8b178f93d,
title = "Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes: A target-specific effect or response to a low-frequency pattern of stimulation?",
abstract = "Deep brain stimulation (DBS) is a reliable treatment for advanced Parkinson's disease (PD) patients, but a possible risk of worsening cognitive functions, although modest, may postpone or halt DBS clinical indication. In a small cohort of PD patients we have pioneered the simultaneous implantation of both the subthalamic nucleus (STN) and the pedunculopontine tegmental nucleus (PPTg). Here we describe the cognitive test performance and the corresponding cortical metabolic activity, as assessed through 18-fluorodeoxyglucose (FDG)-positron emission tomography (PET), of these six PD patients tested in PPTg-ON vs- PPTg-OFF condition. PPTg-ON condition (at low frequency, 25 Hz) induced better performance in tests exploring both executive and attentive domains, which were coupled with an increased glucose utilization in prefrontal and frontal bilateral cortical areas, including both lateral (i.e., BA 9) and more antero-medial cortices (BA 25-32). Moreover, during PPTg-ON, a surprising increase of FDG consumption was also observed in the left ventral striatum. These data are consistent with the hypothesis of a positive effect of 25 Hz PPTg-DBS on PD patients' cognitive profile, probably due to a facilitatory effect exerted by PPTg on both associative and limbic pathways.",
keywords = "Deep brain stimulation, Low frequency stimulation, Parkinson's disease, Pedunculopontine tegmental area, Positron Emission Tomography (PET)",
author = "A. Stefani and M. Pierantozzi and R. Ceravolo and L. Brusa and S. Galati and Paolo Stanzione",
year = "2010",
month = "4",
language = "English",
volume = "41",
pages = "82--86",
journal = "Clinical EEG and Neuroscience",
issn = "1550-0594",
publisher = "EEG and Clinical Neuroscience Society (ECNS)",
number = "2",

}

TY - JOUR

T1 - Deep brain stimulation of pedunculopontine tegmental nucleus (PPTg) promotes cognitive and metabolic changes

T2 - A target-specific effect or response to a low-frequency pattern of stimulation?

AU - Stefani, A.

AU - Pierantozzi, M.

AU - Ceravolo, R.

AU - Brusa, L.

AU - Galati, S.

AU - Stanzione, Paolo

PY - 2010/4

Y1 - 2010/4

N2 - Deep brain stimulation (DBS) is a reliable treatment for advanced Parkinson's disease (PD) patients, but a possible risk of worsening cognitive functions, although modest, may postpone or halt DBS clinical indication. In a small cohort of PD patients we have pioneered the simultaneous implantation of both the subthalamic nucleus (STN) and the pedunculopontine tegmental nucleus (PPTg). Here we describe the cognitive test performance and the corresponding cortical metabolic activity, as assessed through 18-fluorodeoxyglucose (FDG)-positron emission tomography (PET), of these six PD patients tested in PPTg-ON vs- PPTg-OFF condition. PPTg-ON condition (at low frequency, 25 Hz) induced better performance in tests exploring both executive and attentive domains, which were coupled with an increased glucose utilization in prefrontal and frontal bilateral cortical areas, including both lateral (i.e., BA 9) and more antero-medial cortices (BA 25-32). Moreover, during PPTg-ON, a surprising increase of FDG consumption was also observed in the left ventral striatum. These data are consistent with the hypothesis of a positive effect of 25 Hz PPTg-DBS on PD patients' cognitive profile, probably due to a facilitatory effect exerted by PPTg on both associative and limbic pathways.

AB - Deep brain stimulation (DBS) is a reliable treatment for advanced Parkinson's disease (PD) patients, but a possible risk of worsening cognitive functions, although modest, may postpone or halt DBS clinical indication. In a small cohort of PD patients we have pioneered the simultaneous implantation of both the subthalamic nucleus (STN) and the pedunculopontine tegmental nucleus (PPTg). Here we describe the cognitive test performance and the corresponding cortical metabolic activity, as assessed through 18-fluorodeoxyglucose (FDG)-positron emission tomography (PET), of these six PD patients tested in PPTg-ON vs- PPTg-OFF condition. PPTg-ON condition (at low frequency, 25 Hz) induced better performance in tests exploring both executive and attentive domains, which were coupled with an increased glucose utilization in prefrontal and frontal bilateral cortical areas, including both lateral (i.e., BA 9) and more antero-medial cortices (BA 25-32). Moreover, during PPTg-ON, a surprising increase of FDG consumption was also observed in the left ventral striatum. These data are consistent with the hypothesis of a positive effect of 25 Hz PPTg-DBS on PD patients' cognitive profile, probably due to a facilitatory effect exerted by PPTg on both associative and limbic pathways.

KW - Deep brain stimulation

KW - Low frequency stimulation

KW - Parkinson's disease

KW - Pedunculopontine tegmental area

KW - Positron Emission Tomography (PET)

UR - http://www.scopus.com/inward/record.url?scp=77952970323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952970323&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 82

EP - 86

JO - Clinical EEG and Neuroscience

JF - Clinical EEG and Neuroscience

SN - 1550-0594

IS - 2

ER -